Bicycle Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update May 7, 2020
Bicycle Therapeutics Announces First Patient Dosed in Phase I Dose Escalation of BT5528 in Combination with Nivolumab May 5, 2020
